A Placebo Controlled Study to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention vs Early Treatment Approaches (A221701)

A Placebo Controlled Study to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention vs Early Treatment Approaches (A221701)

Trial Category:
Symptom Management
Phase
III
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Faith Regional Health System, Carson Cancer Center, Norfolk, NE
Great Plains Health, Callahan Cancer Center, North Platte, NE
Nebraska Cancer Specialists, Omaha, NE
Nebraska Hematology Oncology, Lincoln, NE
Regional West Health Services, Cancer Center, Scottsbluff, NE
Southeast Nebraska Cancer Center, Lincoln, NE

This study will be looking at the steroid Dexamethasone vs a Placebo  to prevent or improve mouth sores associated with taking the drug Everolimus.                Placebo-Controlled studies are a way of testing a medical therapy in which, in addition to a group of subjects that receives the treatment to be evaluated, a separate control group receives a sham "placebo" treatment which is specifically designed to have no real effect.  The purpose is to determine whether there is any actual positive result of the drug being tested.  In this study, researchers are trying to determine if Dexamethasone can either prevent mouth sores, or lessen the pain associated with mouth sores.  The Dexamethasone/Placebo solution is provided as part of the study.

 

 

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members